Prelude Therapeutics Incorporated

NASDAQ:PRLD

Biotechnology

Healthcare
$3.30 -3.22%

-$0.14 today

Market cap
$191.00M
Beta
1.01
P/E (TTM)
-4.5
EPS (TTM)
-$0.94
52W Low $0.75High $5.54

Volume 0.23M

Average 0.38M

Balance Sheet

Inspect the capital base behind the business.

Assets

$141.31M

FY 2025 · Annual

-19.5% YoY

Liabilities

$72.68M

FY 2025 · Annual

+65.0% YoY

Equity

$68.64M

FY 2025 · Annual

-47.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents31.83M30.61M25.29M12.47M35.26M
Short-term Investments259.41M171.12M207.64M121.14M67.96M
Net Receivables00000
Inventory00000
Other Current Assets02.65M2.65M2.28M2.48M
Total Current Assets295.12M204.38M235.59M135.9M105.69M
Property, Plant & Equipment (Net)5.64M6.7M37.74M35.47M32.28M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets4.35M9.42M4.34M4.15M3.35M
Total Non-current Assets9.98M16.12M42.08M39.62M35.62M
Total Assets305.1M220.5M277.67M175.52M141.32M
Account Payables7.84M6.78M4.58M7.73M3.98M
Short-term Debt00000
Tax Payables00000
Deferred Revenue000033.73M
Other Current Liabilities5.01M6.21M6.61M9.79M5.4M
Total Current Liabilities19.2M21.7M21.83M25.64M52.99M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00001.8M
Other Non-current Liabilities03.36M3.34M3.09M2.84M
Total Non-current Liabilities03.36M18.75M18.42M19.68M
Total Liabilities19.2M25.06M40.58M44.06M72.68M
Common Stock5K5K5K5K5K
Retained Earnings(219.12M)(334.56M)(456.39M)(583.56M)(683.06M)
Accumulated OCI(711K)(1.69M)223K35K8K
Other Stockholders Equity00000
Minority Interest00000
Total Equity285.9M195.44M237.09M131.46M68.64M
Total Debt1.74M1.83M16.89M18.03M17.79M
Net Debt(30.09M)(28.77M)(8.4M)5.55M(17.47M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$21.8M
Short-term Investments$59.8M
Other Current$3.0M
Total Current Assets$84.6M
PP&E (Net)$31.5M
Other Non-current$3.5M
Total Non-current Assets$35.0M
Total Assets$119.6M

Analysis

Selected assets total $119.6M for Latest. The largest visible component is Short-term Investments at $59.8M, about 50.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 10, 2026
10-QQuarterly reportAug 11, 2026
8-KCurrent reportAug 11, 2026
SC 13GSC 13G filingJul 8, 2026
8-KCurrent reportJun 10, 2026

How much cash does PRLD have?

Prelude Therapeutics Incorporated (PRLD) reported $35.26M in cash and equivalents in fiscal 2025.

How much debt does PRLD carry?

Prelude Therapeutics Incorporated (PRLD) reported $17.79M of total debt, with net debt of -$17.47M.